Plasma therapy leads to an increase in functional IgA and IgM concentration in the blood and saliva of a patient with X-linked agammaglobulinemia

BACKGROUND: Patients with X-linked agammaglobulinemia (XLA) are protected against invasive bacterial infections due to IgG replacement therapy, but are still at higher risk for mucosal infections of the gut and respiratory tract. This might be explained by to the lack of IgA and IgM, as these antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Langereis, Jeroen D., Jacobs, Joannes F. M., de Jonge, Marien I., van Deuren, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533670/
https://www.ncbi.nlm.nih.gov/pubmed/31122289
http://dx.doi.org/10.1186/s12967-019-1928-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533670/
https://www.ncbi.nlm.nih.gov/pubmed/31122289
http://dx.doi.org/10.1186/s12967-019-1928-x

Ejemplares similares